Professor Nagwa El-Badri

academic title

Founding Chair of the Biomedical Sciences Program

other title

Director of the Center of Excellence for Stem Cells and Regenerative Medicine

Contact information

Email: nelbadri@zewailcity.edu.eg

Professor Nagwa El-Badri is the founding chair of the biomedical sciences program at the University of Science and Technology, Zewail City. She also serves as the director of the Center of Excellence for Stem Cells and Regenerative Medicine at Zewail City. Prior to joining Zewail City, she was the director of women’s health graduate and undergraduate programs at the University of South Florida’s College of Medicine in the United States.

El-Badri received her Bachelor of Medicine, Bachelor of Surgery (MB Bch) degree with honors from the Faculty of Medicine, Cairo University. She earned her Doctor of Philosophy degree with distinction from the University of South Florida’s College of Medicine. Her postdoctoral training as a fellow of the American Heart Association was in the field of immune tolerance and bone marrow transplantation. She received research support from the Science and Technology Development Fund, American Heart Association, the U.S. National Institutes of Health, and several other foundations. She contributed with more than 40 peer-reviewed publications in the field of stem cell biology and autoimmune disease.

Dr. El-Badri has developed several undergraduate and graduate programs both at Zewail City and the University of South Florida. She received several awards for her efforts in research and in promoting women in science, and was elected as a fellow of the American College of Nutrition. She has mentored more than 100 undergraduate and graduate students in the field of stem cell research. Her research interests include adult stem cell biology, autoimmune diseases and stem cell banking. She was recently awarded a grant of ten million Egyptian pounds from the Science and Technology Development Fund for Centers of Scientific Excellence (STDF-CSE) to establish the Center of Excellence for Stem Cells and Regenerative Medicine at Zewail City of Science and Technology.

El-Badri received her Bachelor of Medicine, Bachelor of Surgery (MB Bch) degree with honors from the Faculty of Medicine, Cairo University. She earned her Doctor of Philosophy degree with distinction from the University of South Florida’s College of Medicine. Her postdoctoral training as a fellow of the American Heart Association was in the field of immune tolerance and bone marrow transplantation.

El-Badri’s research interests include adult stem cell biology, autoimmune diseases and stem cell banking. She received research support from the Science and Technology Development Fund, American Heart Association, the U.S. National Institutes of Health, and several other foundations. She contributed with more than 40 peer-reviewed publications in the field of stem cell biology and autoimmune disease.

 

Award

El-Badri was recently awarded a grant of ten million Egyptian pounds from the Science and Technology Development Fund for Centers of Scientific Excellence (STDF-CSE) to establish the Center of Excellence for Stem Cells and Regenerative Medicine at Zewail City of Science and Technology.

  • El‑Badri, N.S. and Good, R.A. Lymphohemopoietic reconstitution using WGA+ hemopoietic stem cell transplantation within but not across the MHC antigen barriers. Proc. Natl. Acad. Sci., USA 90:6681‑6685, 1993.
  • El‑Badri, N.S. and Good, R.A. Induction of immunological tolerance in full major and multiminor histocompatibility‑disparate mice using a mixed bone marrow transplantation model. Proc. Soc. Exp. Biol. 205:67‑74, 1994.
  • El‑Badri, N.S., Wang, B.Y., Cherry, and Good, R.A. Osteoblasts promote engraftment of allogeneic hematopoietic stem cells. Exp. Hematol. 26:110‑116, 1998.
  • El-Badri N.S., Saporta S, Hakki A, Liang X, Madhusodanan S, Willing AE, Sanberg CD, and Sanberg PR. Cord Blood Mesenchymal Stem Cells: Potential Use in Neurological Disorders. Stem Cells Dev. 15: 497- 506. 2006.
  • El-Badri N. and Ghoneim MA. Mesenchymal Stem Cell Therapy in Diabetes Mellitus: Progress and Challenges. J Nucleic Acids. 2013;2013:194858. doi: 10.1155/2013/194858. Epub 2013 May 15.
 

Quote

Returning to Egypt after my years as a researcher and academician in the U.S. and joining Zewail City represents the fulfillment of my career vision: to be part of the science and technology renaissance in Egypt, and to create a world class biomedical sciences program for the youth of our country.